BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33495272)

  • 1. Spatiotemporal Variations in Growth Rate and Virulence Plasmid Copy Number during
    Schneiders S; Hechard T; Edgren T; Avican K; Fällman M; Fahlgren A; Wang H
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33495272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Growth Rate and Virulence Plasmid Copy Number During Yersinia pseudotuberculosis Infection Using Droplet Digital PCR.
    Hechard T; Wang H
    Methods Mol Biol; 2023; 2674():101-115. PubMed ID: 37258963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasmid copy number is essential for Yersinia T3SS function and virulence.
    Wang H; Avican K; Fahlgren A; Erttmann SF; Nuss AM; Dersch P; Fallman M; Edgren T; Wolf-Watz H
    Science; 2016 Jul; 353(6298):492-5. PubMed ID: 27365311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
    Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
    PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tat Substrate SufI Is Critical for the Ability of Yersinia pseudotuberculosis To Cause Systemic Infection.
    Avican U; Doruk T; Östberg Y; Fahlgren A; Forsberg Å
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of a virulence-associated protein, VagH, of Yersinia pseudotuberculosis reveals a tight link between VagH and the type III secretion system.
    Garbom S; Olofsson M; Björnfot AC; Srivastava MK; Robinson VL; Oyston PCF; Titball RW; Wolf-Watz H
    Microbiology (Reading); 2007 May; 153(Pt 5):1464-1473. PubMed ID: 17464060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-responsive plasmid copy number regulation is dependent on discrete YopD domains in Yersinia pseudotuberculosis.
    Engling P; Héchard T; Edgren T; Francis M; Dersch P; Wang H
    Plasmid; 2023 May; 126():102683. PubMed ID: 37075853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Scale Analysis Reveals IscR Directly and Indirectly Regulates Virulence Factor Genes in Pathogenic
    Balderas D; Mettert E; Lam HN; Banerjee R; Gverzdys T; Alvarez P; Saarunya G; Tanner N; Zoubedi A; Wei Y; Kiley PJ; Auerbuch V
    mBio; 2021 Jun; 12(3):e0063321. PubMed ID: 34060331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes.
    Bliska JB; Brodsky IE; Mecsas J
    EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
    Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
    PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.
    Miller HK; Schwiesow L; Au-Yeung W; Auerbuch V
    Front Cell Infect Microbiol; 2016; 6():69. PubMed ID: 27446816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
    Logsdon LK; Mecsas J
    Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
    Logsdon LK; Mecsas J
    Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.
    Holmström A; Rosqvist R; Wolf-Watz H; Forsberg A
    Infect Immun; 1995 Jun; 63(6):2269-76. PubMed ID: 7768608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LcrQ blocks the role of LcrF in regulating the Ysc-Yop type III secretion genes in Yersinia pseudotuberculosis.
    Li L; Yan H; Feng L; Li Y; Lu P; Hu Y; Chen S
    PLoS One; 2014; 9(3):e92243. PubMed ID: 24658611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
    Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
    Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
    Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
    Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
    Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.